Evidence map›Paper›PMID 42589139›Full record

ArticleBiology2026

In Silico Screening of

Abdul Haseeb Khan, Munazza Kanwal, Syed Babar Jamal, Kashaf Maheen, Sunia Mohsin, Laiba Hussain, Fawaz Al-Hussain, Kaleem Imdad, Shumaila Naz, Shahid Bashir

Abstract read
In one paragraph

Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abdul Haseeb KhanDepartment of Biotechnology, National University of Medical Sciences, Rawalpindi 46000, Pakistan.ORCID 0009-0004-0537-3209
Munazza KanwalDepartment of Biotechnology, National University of Medical Sciences, Rawalpindi 46000, Pakistan.
Syed Babar JamalDepartment of Molecular Biology & Genetics, National University of Medical Sciences, Rawalpindi 46000, Pakistan.ORCID 0000-0001-6916-7376
Kashaf MaheenDepartment of Biotechnology, National University of Medical Sciences, Rawalpindi 46000, Pakistan.ORCID 0009-0003-8235-9032
Sunia MohsinDepartment of Biotechnology, National University of Medical Sciences, Rawalpindi 46000, Pakistan.
Laiba HussainDepartment of Biotechnology, National University of Medical Sciences, Rawalpindi 46000, Pakistan.
Fawaz Al-HussainDepartment of Neurology & Stroke, College of Medicine, King Saud University, Riyadh 11421, Saudi Arabia.
Kaleem ImdadDepartment of Biosciences, COMSATS University Islamabad, Islamabad 45550, Pakistan.ORCID 0000-0001-6051-3383
Shumaila NazDepartment of Biotechnology, National University of Medical Sciences, Rawalpindi 46000, Pakistan.ORCID 0000-0001-8088-0084
Shahid BashirNeuroscience Center, King Fahad Specialist Hospital, Dammam 32253, Saudi Arabia.ORCID 0000-0001-6286-6895

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis remains a major neglected tropical disease with limited therapeutic options, increasing drug resistance, and significant treatment-associated toxicity. Ornithine decarboxylase (ODC), which plays an essential role in polyamine synthesis and survival of parasites, is a potential molecular target for the discovery of anti-leishmanial agents. In this study, 49 natural products with bioactive properties, such as cannabinoids, terpenoids, flavonoids, polyphenols, and alkaloids, are evaluated against ODC using computational approaches like molecular docking and molecular dynamics (MD) simulations. During molecular docking analysis, some compounds showed good affinity binding to the ODC catalytic site, namely Sanguinarine (-8.53 kcal/mol), Rutin (-8.15 kcal/mol), Evodiamine (-7.83 kcal/mol), Cannabinol (-7.58 kcal/mol), and β-sitosterol (-7.56 kcal/mol). Analysis of protein-ligand complex interactions showed that these compounds formed hydrogen bonds, hydrophobic interactions, π-alkyl contacts, π-cation contacts, and van der Waals forces in the vicinity of the active-site amino acid residue. For further analysis, MD simulations were performed for 100 ns on the best-docking complexes. Comparative trajectory analysis of RMSD, RMSF, Rg, SASA, and hydrogen bonds was conducted, revealing that Rutin and Evodiamine exhibited relatively high structural stability and consistent interactions within the ODC binding cavity. Overall, this study indicates that the natural compounds analyzed here could be considered promising hit compounds for anti-leishmanial drug discovery against ODC. However, further investigations using experimental techniques are required to confirm their biological properties and efficacy.

Indexed as

anti-leishmanial prioritized compound discoveryCannabis sativaLeishmaniamolecular dockingmolecular dynamics simulationsornithine decarboxylasephytochemicals

Identifiers

PMID42589139
PMCPMC13465575

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.